Skip to main content
Top
Published in: Clinical & Experimental Metastasis 8/2002

01-12-2002

Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer

Authors: Alexandra Giatromanolaki, Efthimios Sivridis, Constantinos Simopoulos, Alexandros Polychronidis, Kevin C. Gatter, Adrian L. Harris, Michael I. Koukourakis

Published in: Clinical & Experimental Metastasis | Issue 8/2002

Login to get access
Metadata
Title
Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer
Authors
Alexandra Giatromanolaki
Efthimios Sivridis
Constantinos Simopoulos
Alexandros Polychronidis
Kevin C. Gatter
Adrian L. Harris
Michael I. Koukourakis
Publication date
01-12-2002
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 8/2002
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1021354028685

Other articles of this Issue 8/2002

Clinical & Experimental Metastasis 8/2002 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine